A Study of LY3541105 in Healthy and Overweight Participants

NCT05380323 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

206

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Healthy

Interventions

DRUG: LY3541105
DRUG: Placebo

Sponsor

Eli Lilly and Company